Trifluridine/tipiracil hydrochloride mixture
博飞美科提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
PN04905
PERFEMIKER
733030-01-8
C29H34Cl2F6N8O12
871.53
-20°C for 3 years | In solvent: -80°C for 1 year
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
| 产品名称: |
TAS-102 |
| 中文别名: |
TAS-102;化合物TAS102;化合物TAS102;三氟尿嘧啶-TIPIRACIL盐酸盐混合物;三氟尿嘧啶-TIPIRACIL盐酸盐混合物;1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-(三氟甲基)嘧啶-2,4(1H,3H)-二酮 5-氯-6-((2-亚氨基吡咯烷-1-基)甲基)嘧啶-2,4(1H,3H)二酮盐酸盐(1:1);1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-(三氟甲基)嘧啶-2,4(1H,3H)-二酮 5-氯-6-((2-亚氨基吡咯烷-1-基)甲基)嘧啶-2,4(1H,3H)二酮盐酸盐(1:1);TAS-102(盐酸曲氟尿苷);TAS-102(盐酸曲氟尿苷);1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-(三氟甲基)嘧啶-2,4(1H,3H)-二酮 5-氯-6-((2-亚氨基吡咯烷-1-基)甲基)嘧啶-2,4(1H,3H)二酮盐酸盐;1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-(三氟甲基)嘧啶-2,4(1H,3H)-二酮 5-氯-6-((2-亚氨基吡咯烷-1-基)甲基)嘧啶-2,4(1H,3H)二酮盐酸盐;化合物 TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE MIXTURE;化合物 TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE MIXTURE |
| 英文名称: |
Trifluridine/tipiracil hydrochloride mixture |
| 英文别名: |
5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione,1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione,hydrochloride;TAS102;TAS-102;Trifluridine-tipiracil hydrochloride mixture;5-Chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione;1-[(4S,5R)-4-hydroxy-5-(hydroxym;Trifluridine/tipiracil hydrochloride mixture;Tipiracil hydrochloride-trifluridine mixt.;Tipiracil hydrochloride-trifluridine mixt.;TRIFLURIDINE-TIPIRACIL HYDROCHLORIDE MIXTURE;TRIFLURIDINE-TIPIRACIL HYDROCHLORIDE MIXTURE;TAS-102(Tipiracil hydrochloride-trifluridine mixt);TAS-102(Tipiracil hydrochloride-trifluridine mixt);Trifluridine-tipiracil hydrochloride mixt.;Trifluridine-tipiracil hydrochloride mixt.;TAS-102(TIPIRACIL, TRIFLURIDINE);TAS-102(TIPIRACIL, TRIFLURIDINE);TAS-102 (LONSURF);TAS-102 (LONSURF); TAS 102; TAS 102 |
| 品牌: |
PERFEMIKER |
| CAS号: |
733030-01-8 |
| 分子式: |
C29H34CL2F6N8O12 |
| 分子量: |
871.53 |
| 纯度: |
≥99% |
| 详细描述: |
Trifluridine/tipiracil hydrochloride mixture (TAS-102) 是一种新型口服组合药物,含有摩尔比为 2:1 的曲氟尿苷(TFT) 和盐酸替吡嘧啶 (TTP)。它主要通过抑制胸苷酸合酶 (TS) 和掺入 DNA 来显示抗肿瘤活性。 |